Improving business performance in medical device manufacturing companies through supplier relationships

Sammanfattning: Background: The globalization of markets, competition in the market place, shareholder activism has compelled firms to rethink their way of doing business. In today’s world stakeholders are placing much emphasis on supplier relationships given that the survival of firms depends on the type of relationship that exists between the supplier and the buying firm. The maintenance of supplier relationships is a complex task due to differences in interest and the opportunistic behaviour which may be on the part of the supplier or the buyer. For this reason, firms have to look out for supplier relationships that can improve their business performance and enhance their competitive advantage. Purpose:     The purpose of the study was to investigate the relationship that exists between medical devices manufacturers in Sweden and their key suppliers, and the reasons for establishing relationships. The authors were also interested in knowing how this relationship ultimately leads to improved business performance. Method: The authors used positivist perspective and a deductive approach for this thesis. The sampled firms in this study are Arcoma AB, Baxter and Cellavision and a convenience sampling method was used in selecting the companies. The empirical data for this study was collected through interviews with senior management personnel of the three companies whose head offices are located Lund and Växjö in Sweden. Results, conclusions: The supplier relationships established by Arcoma, Baxter and Cellavision, and their key suppliers was found to be collaborative. The quests to improve on quality, reduce cost and increase the responsiveness of the supply chain are some of the reasons why firms establish collaborative relationships. Establishing collaborative relationships with key suppliers leads to improved operational and financial business performance. Improvements in operational business performance could be in the form of reduction in defects, improved compliance with quality standards, and improvement in delivery reliability and reduced lead times. The benefits to the firms in terms of financial performance stems from cost reduction and the offering of competitive prices in the marketplace which leads to increased market share and revenue expansion.